CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Why CROs Essential in Drug Development

Life Sciences Review | Friday, April 30, 2021
Tweet

In the pharma industry, where time is of the essence, CROs are a fantastic resource in helping bring much-needed drugs and treatments to patients.


FREMONT, CA: Outsourcing of non-core services and resources is a usual practice in the business world as firms look to mitigate overhead and costs and optimize their businesses. Pharmaceutical firms outsource their clinical research potentials to contract research organizations (CROs) for several reasons, including therapeutic expertise of the CRO, cost advantages, and geographic reach. But, ultimately, they do it to assist in bringing new drugs and treatments to patients quicker. While CROs are the outsourcing partners for the life sciences industry, other sectors are equally familiar with the concept. Tech firms have also been key proponents of outsourcing over the years. Here is more to know.


The pandemic has put the pharmaceutical sector in the spotlight, sparking heightened levels of public interest in the clinical development operation. It is extensively recognized that the latest innovations in the sector and the clinical successes during the COVID-19 would not have been possible without the assistance of CROs. CROs are a significant resource for pharmaceutical firms. 


They are fast to adopt the latest technologies, allowing them to offer unique insights and advice, spotting novel and distinctive ways of leveraging these advanced tools and adapting them to each sponsor's requirements to ensure optimal clinical trial performance.


In clinical trials, the pace is fundamental, and this has been even more essential in battling Covid-19, with pressure on the sector to offer a vaccine in the shortest time possible. While sponsors play a significant role in these clinical trials, the delivery wouldn't have been possible without the expertise and vast resources brought by collaborating with CROs. CROs are at the forefront of deploying the latest technologies available to manage competitive advantage and ensure they can provide customers with the full spectrum of available solutions. Given that the global CROs work with hundreds of sponsors, they have a learning curve of experience beyond any sponsor.  CROs should be considered more than mere useful resources — they should be thought of as partners in the drug development journey.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/why-cros-essential-in-drug-development-nwid-349.html